Catherine Avery Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03K Buy
+13
New +$4.82K ﹤0.01% 137
2026
Q1
Sell
-13
Closed -$4.56K 123
2025
Q4
$4.56K Hold
13
﹤0.01% 121
2025
Q3
$4.2K Hold
13
﹤0.01% 125
2025
Q2
$5.06K Hold
13
﹤0.01% 120
2025
Q1
$5.65K Hold
13
0.01% 113
2024
Q4
$4.8K Buy
+13
New +$5.44K ﹤0.01% 114

Other funds holding ELV

Catherine Avery Investment Management's ELV Position: Q2 2026 in Review

Catherine Avery Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 13 shares worth $5.03K. The stake represents ﹤0.01% of the portfolio and ranks #137 among its holdings. This is a return to the name: Catherine Avery Investment Management previously reported a position in ELV as recently as Q4 2025.

Catherine Avery Investment Management first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.65K in Q1 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Catherine Avery Investment Management held 13 shares of Elevance Health worth $5.03K as of Q2 2026.
  • Elevance Health was a new Catherine Avery Investment Management position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Catherine Avery Investment Management's portfolio in Q2 2026, its #137 holding.
  • Catherine Avery Investment Management first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Catherine Avery Investment Management's Elevance Health position peaked at $5.65K in Q1 2025.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.